Corpus Intelligence IC Memo — ST. JOSEPHS BEHAVIORAL HLTH CENTER 2026-04-26 14:15 UTC
IC Memo — ST. JOSEPHS BEHAVIORAL HLTH CENTER
Investment Committee Memorandum | CA | 35 beds | Grade D | EBITDA uplift $1.5M
🛡️ Public data only — no PHI permitted on this instance.
Investment Committee Memorandum

ST. JOSEPHS BEHAVIORAL HLTH CENTER

CCN 054123 | SAN JOAQUIN, CA | 35 beds | April 26, 2026
EBITDA BridgeData Room
D
Investability

1. Target Overview & Investment Thesis

ST. JOSEPHS BEHAVIORAL HLTH CENTER is a 35-bed community hospital in SAN JOAQUIN, CA with $19.9M in net patient revenue and a -20.5% operating margin. The hospital serves a payer mix of 22.6% Medicare, 0.0% Medicaid, and 77.4% commercial.

Thesis: Turnaround. Our ML models identify $1.5M in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from -20.5% to -13.2% (+736bps).

Net Revenue HCRIS$19.9M
Current EBITDA COMPUTED$-4.1M
Operating Margin COMPUTED-20.5%
Occupancy HCRIS88.4%
Revenue / Bed COMPUTED$568K
Net-to-Gross HCRIS46.0%
Distress Probability MLnan%

2. Market Context & Competitive Position

414
CA Hospitals
-4.9%
State Median Margin
81
Comparable Hospitals

CA has 414 Medicare-certified hospitals with a median operating margin of -4.9%. The target's margin of -20.5% places it below the state median. Among 81 size-comparable peers (18-70 beds), the median margin is -6.2%. The target's below-peer margin suggests operational improvement opportunity.

3. RCM Performance Analysis — Comparable Hospitals

Comps selected by bed count (18-70), prioritizing same-state peers. 81 hospitals in the comp set.

HospitalStateBedsRevenueMargin
ST. JOSEPHS BEHAVIORAL HLTH CE (Target)CA35$19.9M-20.5%
USC NORRIS CANCER HOSPITALCA60$468.7M19.1%
TAHOE FOREST HOSPITALCA25$264.3M13.0%
SUTTER AUBURN FAITH HOSPITALCA64$189.3M3.8%
ADVENTIST HEALTH REEDLEYCA49$187.1M1.8%
SUTTER DAVIS HOSPITALCA48$176.9M12.5%
ADVENTIST HEALTH UKIAH VALLEYCA50$173.4M-39.9%
SAN MATEO MEDICAL CENTERCA69$169.7M-50.0%
BARTON MEMORIAL HOSPITALCA63$165.8M-26.7%

4. Predicted Improvement Opportunities

Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $1.5M (736bps margin improvement).

LeverCurrentTargetEBITDA ImpactMarginRamp
Net Collection Rate93.5%97.0%$417K+210bp18mo
Cost to Collect4.5%2.5%$398K+200bp12mo
Denial Rate Reduction12.0%6.5%$394K+198bp12mo
A/R Days Reduction5200.0%3800.0%$242K+122bp9mo
Clean Claim Rate88.0%96.0%$13K+6bp6mo

5. EBITDA Bridge

Net Collection Rate
$417K
Cost to Collect
$398K
Denial Rate Reduction
$394K
A/R Days Reduction
$242K
Clean Claim Rate
$13K
Total EBITDA Uplift$1.5M
Current EBITDA$-4.1M
+ RCM Uplift+$1.5M
Pro Forma EBITDA$-2.6M
Current Margin-20.5%
Pro Forma Margin-13.2%
WC Released (1x)$763K

6. Returns Analysis — Scenario Matrix

5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.

ScenarioEntryExitEquity InEquity OutMOICIRR
Base Case10.0x10.0x$-6.3M$-12.3M0.00x-100.0%
Base (11x exit)10.0x11.0x$-6.3M$-15.6M0.00x-100.0%
Bull Case9.0x11.0x$-5.7M$-12.8M0.00x-100.0%
Bull (12x exit)9.0x12.0x$-5.7M$-15.6M0.00x-100.0%
Bear Case11.0x10.0x$-6.9M$-17.6M0.00x-100.0%
Bear (11x exit)11.0x11.0x$-6.9M$-21.6M0.00x-100.0%

7. Key Risks & Mitigants

SeverityRisk FactorMitigant
HighNegative operating marginRCM uplift bridge shows clear path to profitability; working capital release provides near-term cash cushion

8. Data Sources & Methodology Appendix

Data Sources

  • CMS HCRIS Cost Reports (Medicare-certified hospitals)
  • CMS Medicare Utilization (DRG-level volumes)
  • CMS Chronic Conditions (county-level disease prevalence)
  • HCRIS multi-year trend data (financial time series)

Comparable Selection

  • 81 hospitals with 18-70 beds
  • Same-state prioritization (n=82)
  • Comp margins: P25=-17.6% / P50=-6.2% / P75=1.8%

Bridge Methodology

  • Targets: P75 of comparable peers (60% gap closure)
  • Denial: avoidable share = 35% of delta × NPR
  • AR: bad debt coefficient = $0.65 per day per $1K NPR
  • NCR: 60% coefficient on collection rate improvement
  • CDI: 0.75% of Medicare revenue per 0.01 CMI point

Returns Assumptions

  • Leverage: 5.5x entry (84.6% debt / 15.4% equity)
  • Organic growth: 3% annual EBITDA growth
  • Debt paydown: 10% of principal per year
  • Hold period: 5 years

Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.